Skip to content

Clinical trials

Phase 1 Renal Insufficiency, Chronic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency, Chronic Phase: Phase 1 Country / region: United States Clear all

92 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20083
20091
20102
20115
20121
201312
20145
20156
20163
20174
20182
20199
20203
20215
20225
20234
20247
20254
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed69
Recruiting11
Terminated5
Active, not recruiting3
Not yet recruiting2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca8
Akebia Therapeutics4
Mayo Clinic4
Eli Lilly and Company3
Renibus Therapeutics, Inc.3
Amgen2
Brigham and Women's Hospital2
Cara Therapeutics, Inc.2
Denver Nephrologists, P.C.2
Emory University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency, Chronic92
Kidney Failure, Chronic15
Renal Insufficiency15
Kidney Diseases9
Anemia8
Diabetes Mellitus, Type 28
Diabetic Nephropathies5
Hyperparathyroidism, Secondary5
Acidosis3
Diabetes Mellitus3

Trials

Showing 1 to 25 of 92. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.